Regeneron Patents

Patent portfolio assigned to Regeneron (verified via public assignee records). Large public biotech (Regeneron Pharmaceuticals), not a startup. Listed names are major collaboration partners (Sanofi for Dupixent/Libtayo; Bayer for Eylea ex-US), not customers. Holds an extensive antibody patent portfolio (assignee 'Regeneron Pharmaceuticals, Inc.').